media – Page 573 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Aspyrian Therapeutics Inc. announces successful advances in RM-1929 clinical development

Aspyrian Therapeutics Inc. announces successful advances in RM-1929 clinical development in recurrent Head and Neck Cancer, including Fast Track designation granted by the FDA, initiation of clinical studies in Japan, and plans to start pivotal studies, which will incorporate the evaluation of anti-cancer immune responses, in early 2018.
- Source: Prnewswire
- 749
- January 19, 2018
anti-cancer immune New Approvals RM-1929
Blood cancer care needs improving, finds MP inquiry

The Government’s 2015 Cancer Strategy is failing to support blood cancer patients in the UK and care must improve, an MP inquiry has found.
- Source: pharmatimes
- 649
- January 19, 2018
blood cancer NHS polices
J&J attracts Chinese interest for diabetes business in potential $3B to $4B deal

Chinese bidders are circling a diabetes care business owned by the world's largest health-care company Johnson & Johnson in a deal that could fetch up to $4 billion, five people with direct knowledge told Reuters.
- Source: Cnbc;
- 490
- January 19, 2018
diabetes Market Views
Stimwave scoops $50M to step up pain device sales push

Stimwave has raised $50 million to support commercialization of its neuromodulation pain therapies. The financing equips Stimwave to push ahead with its previously disclosed plans to make its devices available across the U.S.
- Source: fiercebiotech
- 606
- January 19, 2018
Market Views neuromodulation pain therapies Series
China International Medical Devices Exhibition 2018

After successfully holding nineteen sessions’ exhibition, CMEH has experienced rapid development over the past years and has now become one of the largest international medical equipment fair.
- Source: Ddu
- 4,955
- January 19, 2018
CMEH Exhibitions & Activities medical device
AI funding tops $1 billion mark as mobile investments wane

Health IT funding set a record in 2017 with AI and predictive analytics as top tech funded, with patient engagement, telehealth and clinical decision support close behind.
- Source: Healthcare IT News
- 836
- January 19, 2018
AI digital health healthcare technology Market Views
Meet Ddu in Dubai–The First Medical Exhibition of 2018

The Arab Health Exhibition 2018 will be held at the Dubai International Convention & Exhibition Centre from January 29th to February 1st, 2018. Ddu, the leading global pharmaceutical & medical device B2B online platform, will once again attend the exhibition, showcasing the changes that the Internet has brought to cross-border medical trade to the visitors in Dubai, as well as our global audience.
- Source: Ddu
- 1,044
- January 19, 2018
Arab Health Exhibitions & Activities
Potentially life-saving health monitor

Sick babies in remote parts of the world could be monitored from afar, thanks to new wearable technology designed by physicists at the University of Sussex.
- Source: Printed Electronics World
- 708
- January 19, 2018
health monitor Researches wearables
Smiths updates recall for Medfusion syringe pumps

Smiths Medical has amended an urgent medical device recall that it first issued in August for its Medfusion syringe pump model series 3500 and 4000.
- Source: Drug Delivery Business
- 799
- January 19, 2018
Company Insight medical device syringe pump
Novartis granted US FDA Priority Review for Kymriah(TM) (tisagenlecleucel), formerly CTL019, for adults with r/r DLBCL

Novartis today announced that its supplemental Biologics License Application (sBLA) for KymriahTM (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, for the treatment of adult patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL) who are ineligible for or relapse after autologous stem cell transplant (ASCT) has been accepted by the US Food and Drug Administration (FDA) for Priority Review.
- Source: Novartis
- 403
- January 18, 2018
DLBCL New Approvals sBLA

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.